Shelter Pharma, 543963, Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

50.51
6.98
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

48.13
1.17%
0.84

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales - 50.66 40.02 36.15 30.06 22.48 30.07 27.73 31.46 30.01 28.14 Net Sales Growth - 26.59% 10.71% 20.26% 33.72% -25.24% 8.44% -11.86% 4.83% 6.65% Cost Of Goods Sold - 37.03 28.92 26.25 25.85 21.14 28.30 25.70 29.22 28.73 26.34 Gross Profit - 13.63 11.10 9.90 4.21 1.34 1.77 2.03 2.24 1.27 1.80 GP Margin - 26.90% 27.74% 27.39% 14.01% 5.96% 5.89% 7.32% 7.12% 4.23% 6.40% Total Expenditure - 40.60 31.24 28.09 27.32 22.29 29.82 27.55 31.30 30.70 27.98 Power & Fuel Cost - 0.08 0.07 0.06 0.05 0.05 0.07 0.07 0.07 0.06 0.05 % Of Sales - 0.16% 0.17% 0.17% 0.17% 0.22% 0.23% 0.25% 0.22% 0.20% 0.18% Employee Cost - 1.22 0.63 0.45 0.35 0.33 0.39 0.39 0.52 0.47 0.43 % Of Sales - 2.41% 1.57% 1.24% 1.16% 1.47% 1.30% 1.41% 1.65% 1.57% 1.53% Manufacturing Exp. - 0.23 0.24 0.27 0.16 0.16 0.25 0.35 0.41 0.35 0.15 % Of Sales - 0.45% 0.60% 0.75% 0.53% 0.71% 0.83% 1.26% 1.30% 1.17% 0.53% General & Admin Exp. - 1.26 0.70 0.56 0.56 0.58 0.75 0.85 0.91 0.84 0.86 % Of Sales - 2.49% 1.75% 1.55% 1.86% 2.58% 2.49% 3.07% 2.89% 2.80% 3.06% Selling & Distn. Exp. - 0.23 0.22 0.10 0.04 0.06 0.07 0.18 0.15 0.18 0.15 % Of Sales - 0.45% 0.55% 0.28% 0.13% 0.27% 0.23% 0.65% 0.48% 0.60% 0.53% Miscellaneous Exp. - 0.56 0.45 0.39 0.31 -0.02 0.00 0.01 0.03 0.07 0.15 % Of Sales - 1.11% 1.12% 1.08% 1.03% -0.09% 0% 0.04% 0.10% 0.23% 0% EBITDA - 10.06 8.78 8.06 2.74 0.19 0.25 0.18 0.16 -0.69 0.16 EBITDA Margin - 19.86% 21.94% 22.30% 9.12% 0.85% 0.83% 0.65% 0.51% -2.30% 0.57% Other Income - 0.02 0.01 0.00 0.02 0.01 0.01 0.02 0.01 0.83 0.00 Interest - 0.13 0.26 0.03 0.08 0.02 0.01 0.00 0.00 0.01 0.01 Depreciation - 0.27 0.25 0.16 0.17 0.12 0.13 0.12 0.10 0.07 0.10 PBT - 9.68 8.28 7.88 2.51 0.06 0.11 0.08 0.07 0.06 0.05 Tax - 2.44 2.08 1.78 0.67 0.02 0.03 0.02 0.01 0.01 0.01 Tax Rate - 25.21% 25.12% 25.50% 26.69% 33.33% 27.27% 25.00% 14.29% 16.67% 20.00% PAT - 7.24 6.20 5.21 1.84 0.04 0.08 0.06 0.05 0.05 0.05 PAT before Minority Interest - 7.24 6.20 5.21 1.84 0.04 0.08 0.06 0.05 0.05 0.05 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 14.29% 15.49% 14.41% 6.12% 0.18% 0.27% 0.22% 0.16% 0.17% 0.18% PAT Growth - 16.77% 19.00% 183.15% 4,500.00% -50.00% 33.33% 20.00% 0.00% 0.00% EPS - 4.36 3.73 3.14 1.11 0.02 0.05 0.04 0.03 0.03 0.03

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 42.72 35.82 14.55 8.93 7.11 6.98 7.69 7.63 7.78 7.77 Share Capital 11.56 11.56 7.74 0.48 0.48 0.45 0.45 0.45 0.45 0.45 Total Reserves 31.16 24.26 6.80 8.44 6.63 6.53 7.23 7.17 7.32 7.31 Non-Current Liabilities 0.95 0.59 0.65 0.20 0.19 0.18 0.10 0.10 0.10 0.06 Secured Loans 0.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.37 0.57 0.48 0.06 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.05 0.05 0.05 0.04 0.09 0.08 0.00 0.00 0.00 0.00 Current Liabilities 4.63 4.98 6.25 3.71 2.90 3.47 3.21 3.08 3.76 3.73 Trade Payables 1.25 0.71 0.47 0.32 0.31 0.26 0.19 0.15 0.17 0.18 Other Current Liabilities 0.07 0.06 2.62 2.69 2.53 2.92 2.74 2.55 2.84 0.82 Short Term Borrowings 0.11 0.00 1.30 0.04 0.00 0.24 0.16 0.07 0.11 2.07 Short Term Provisions 3.20 4.20 1.85 0.65 0.06 0.05 0.13 0.31 0.65 0.66 Total Liabilities 48.30 41.39 21.45 12.84 10.20 10.63 11.00 10.81 11.64 11.56 Net Block 5.96 3.58 1.85 1.45 1.57 1.77 2.69 2.67 2.71 2.61 Gross Block 8.36 5.70 3.72 3.17 3.12 3.11 3.51 3.37 3.31 3.28 Accumulated Depreciation 2.39 2.13 1.88 1.72 1.55 1.34 0.82 0.70 0.60 0.67 Non Current Assets 15.03 8.16 2.73 3.01 2.32 2.57 3.37 3.06 3.02 2.76 Capital Work in Progress 0.00 0.00 0.00 0.55 0.00 0.00 0.22 0.13 0.11 0.14 Non Current Investment 0.68 0.68 0.68 0.68 0.68 0.68 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 8.39 3.90 0.21 0.33 0.08 0.12 0.46 0.26 0.20 0.01 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 33.28 33.22 18.72 9.83 7.88 8.07 7.63 7.75 8.62 8.79 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 12.90 9.93 7.96 5.67 4.02 4.31 4.12 3.81 3.91 4.43 Sundry Debtors 9.47 8.85 8.19 1.61 0.76 0.61 0.06 0.59 1.16 1.00 Cash & Bank 3.42 5.04 0.43 0.10 0.37 0.14 0.12 0.08 0.08 0.10 Other Current Assets 7.49 0.00 0.00 0.00 2.73 3.01 3.32 3.27 3.47 3.27 Short Term Loans & Adv. 7.49 9.40 2.13 2.45 2.73 3.01 3.32 3.27 3.47 3.27 Net Current Assets 28.65 28.24 12.47 6.12 4.98 4.60 4.42 4.67 4.85 5.06 Total Assets 48.31 41.38 21.45 12.84 10.20 10.64 11.00 10.81 11.64 11.55

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 5.48 -1.96 -0.96 0.52 0.00 0.00 0.00 PBT 9.68 8.28 7.05 2.51 0.00 0.00 0.00 Adjustment 0.26 0.58 0.17 0.05 0.00 0.00 0.00 Changes in Working Capital -2.02 -9.26 -8.19 -2.04 0.00 0.00 0.00 Cash after chg. in Working capital 7.92 -0.40 -0.96 0.52 0.00 0.00 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.44 -1.56 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.13 -4.54 0.11 -0.85 0.00 0.00 0.00 Net Fixed Assets -2.66 -1.98 0.00 -0.30 0.00 -0.28 Net Investments 0.00 0.00 0.00 -0.68 0.00 0.00 Others -4.47 -2.56 0.11 0.13 0.00 0.28 Cash from Financing Activity 0.03 11.12 1.18 0.06 0.00 0.00 0.00 Net Cash Inflow / Outflow -1.62 4.61 0.33 -0.27 0.00 0.00 0.00 Opening Cash & Equivalents 5.04 0.43 0.10 0.37 0.00 0.00 0.00 Closing Cash & Equivalent 3.42 5.04 0.43 0.10 0.00 0.00 0.00

Financial Ratios

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 36.14 30.17 17.57 10.31 206.99 170.15 68.58 84.09 29.73 24.22 ROA 16.14% 19.74% 30.37% 15.94% 11.67% 12.01% 10.25% 9.94% 4.81% 8.68% ROE 18.88% 25.58% 48.22% 25.95% 19.54% 26.40% 29.81% 27.77% 20.29% 42.68% ROCE 25.07% 33.62% 59.61% 36.17% 22.50% 25.25% 26.91% 26.11% 29.22% 36.53% Fixed Asset Turnover 7.21 8.49 10.49 9.57 9.63 10.20 9.65 7.79 6.15 5.48 Receivable days 66.01 77.72 49.47 14.36 61.36 66.14 82.44 74.53 38.46 21.47 Inventory Days 82.22 81.59 68.85 58.83 73.90 46.30 27.29 28.52 26.12 27.29 Payable days 9.68 7.45 5.49 4.48 9.95 6.86 26.68 28.12 1.94 2.99 Cash Conversion Cycle 138.55 151.86 112.83 68.72 125.30 105.59 83.05 74.93 62.63 45.77 Total Debt/Equity 0.03 0.02 0.13 0.02 0.22 0.27 1.72 0.62 1.54 1.14 Interest Cover 72.95 32.42 278.06 32.60 2441.20 13.03 5.01 3.67 2.81 2.81

Top Investors:

misbahul mohmed panchbhai

rifat misbah panchbhai

rishabh nayanbhai sharma

nurjaha mohamedyusuf lala

mariyambibi moyusuf akuli

lala mohmadyusuf g

shahnawaz mohmadyusuf lala

shaikh shabnam mohammedrafiq

Annual Reports:

News Update:

Shelter Pharma to launch ‘FOLIMAN Folic Acid Tablets’
11th May 2026, 11:51 AM

The launch is expected to strengthen the company’s presence in the healthcare segment and contribute towards future business growth
Read More
Shelter Pharma bags repeat purchase orders from Taha Drugs & Chemicals Co
5th May 2026, 14:11 PM

The company has received purchase orders for supply of nutraceutical products
Read More
Shelter Pharma bags order from Taha Drugs & Chemicals Co
30th Apr 2026, 16:58 PM

The order is to be executed within the mutually agreed timelines as per purchase order and shipment schedule
Read More
Shelter Pharma secures order from Taha Drugs & Chemicals Co
29th Apr 2026, 14:20 PM

The company has secured order for Joemega Capsule and All Vitamins tablet
Read More
Shelter Pharma bags order worth $18,300
12th Mar 2026, 16:12 PM

The order is to be executed within 6 months
Read More

Shelter Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543963 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Shelter Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543963 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: